You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Label for Simvastatin Revised Again

Aschenbrenner, Diane S. MS, RN

AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000414313.56707.a3
Drug Watch
Abstract

* The Food and Drug Administration has reversed its June 2011 decision to reduce the maximum daily dosage of the cholesterol-lowering drug simvastatin (Zocor) when it's coadministered with amiodarone (Cordarone), stating that the agency had reduced the dosage in error; 20 mg is again the maximum dosage.

Author Information

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch: dianea@son.jhmi.edu.

© 2012 Lippincott Williams & Wilkins, Inc.